Potential celiac disease drug that breaks down gluten protects against damage to the small intestine
Article originally published on BeyondCeliac.org by Amy Ratner, director of scientific affairs A drug designed to break gluten into...
top of page
News & Articles
Search
Beyond Celiac
- Oct 14, 2020
- 1 min
PHASE 2 STUDY RELAUNCHING IN NOVEMBER
by Kate Avery, MPH, Director of Research & Patient Engagement ImmunogenX put the Solutions for Celiac study (NCT04243551) on hold in...
64
Celiac Disease Foundation
- Feb 13, 2020
- 2 min
Celiac Disease Patients on a Gluten-Free Diet Still Ingest Gluten
Persistent gluten exposure is known to lead to lifelong health issues in people with celiac disease, including anemia, malnutrition, and...
52
Beyond Celiac
- Feb 3, 2020
- 2 min
NEW PHASE 2 CLINICAL TRIAL FOR SYMPTOMATIC CELIAC DISEASE PATIENTS LAUNCHES
Testing of latiglutenase to relieve symptoms in celiac disease patients continues with the launch of a clinical trial in December This...
239
Beyond Celiac
- Jan 24, 2020
- 3 min
POTENTIAL DRUG FOR CELIAC DISEASE IMPROVES SYMPTOMS AND QUALITY OF LIFE IN SOME PATIENTS
Study participants whose blood tests showed gluten exposure saw latiglutenase benefits
44
Celiac Disease Foundation
- Dec 18, 2019
- 2 min
Latiglutenase for Celiac Disease Shows Symptom, Quality of Life Improvement
ImmunogenX, a clinical stage biotherapeutics company, has published the results of their phase 2 trial testing latiglutenase—an orally...
61
Beyond Celiac
- Nov 28, 2017
- 3 min
BREAKING DOWN GLUTEN TO TREAT CELIAC DISEASE
Investigation of new drug that could help patients struggling with symptoms gets NIH grant
24
Sign up for our clinical trial today
bottom of page